TrialRMD open2022

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study.

Nina Paulshus Sundlisæter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.